_id
6915e713bc934aba376b1ace
Ticker
PRME
Name
Prime Medicine, Inc. Common Stock
Exchange
NASDAQ
Address
60 First Street, Cambridge, MA, United States, 02141
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://primemedicine.com
Description
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Last Close
4.27
Volume
4249828
Current Price
4.1
Change
-3.981264637002341
Last Updated
2025-12-03T12:21:46.915Z
Image
data:image/webp;base64,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
Ipo Date
2022-10-20T00:00:00.000Z
Market Cap
595685184
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.748
Sentiment Sources
4
Rating
4.1667
Target Price
6.4643
Strong Buy
6
Buy
2
Hold
4
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1225000
Cost Of Revenue
43990000
Gross Profit
-42765000
Operating Expenses
11208000
Operating Income
-53973000
Interest Expense
-
Pretax Income
-50582000
Net Income
-50582000
Eps
-0.3151463980623985
Dividends Per Share
-
Shares Outstanding
180510658
Income Tax Expense
-
EBITDA
-48701000
Operating Margin
-4405.95918367347
Total Other Income Expense Net
3391000
Cash
71396000
Short Term Investments
137030000
Receivables
-
Inventories
-
Total Current Assets
231406000
Property Plant Equipment
139915000
Total Assets
385012000
Payables
9354000
Short Term Debt
7714000
Long Term Debt
-
Total Liabilities
223191000
Equity
161821000
Depreciation
1881000
Change In Working Capital
609000
Cash From Operations
-35039000
Capital Expenditures
247000
Cash From Investing
-92122000
Cash From Financing
144753000
Net Change In Cash
17592000
PE
-
PB
4.066610948517189
ROE
-31.257994945031857
ROA
-13.137772329174155
FCF
-35286000
Fcf Percent
-28.804897959183673
Piotroski FScore
1
Health Score
20
Deep Value Investing Score
2
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1225000
Quarters > 0 > income Statement > cost Of Revenue
43990000
Quarters > 0 > income Statement > gross Profit
-42765000
Quarters > 0 > income Statement > operating Expenses
11208000
Quarters > 0 > income Statement > operating Income
-53973000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-50582000
Quarters > 0 > income Statement > net Income
-50582000
Quarters > 0 > income Statement > eps
-0.3151463980623985
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
160503183
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-48701000
Quarters > 0 > income Statement > operating Margin
-4405.95918367347
Quarters > 0 > income Statement > total Other Income Expense Net
3391000
Quarters > 0 > balance Sheet > cash
71396000
Quarters > 0 > balance Sheet > short Term Investments
137030000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
231406000
Quarters > 0 > balance Sheet > property Plant Equipment
139915000
Quarters > 0 > balance Sheet > total Assets
385012000
Quarters > 0 > balance Sheet > payables
9354000
Quarters > 0 > balance Sheet > short Term Debt
7714000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
223191000
Quarters > 0 > balance Sheet > equity
161821000
Quarters > 0 > cash Flow > net Income
-50582000
Quarters > 0 > cash Flow > depreciation
1881000
Quarters > 0 > cash Flow > change In Working Capital
609000
Quarters > 0 > cash Flow > cash From Operations
-35039000
Quarters > 0 > cash Flow > capital Expenditures
247000
Quarters > 0 > cash Flow > cash From Investing
-92122000
Quarters > 0 > cash Flow > cash From Financing
144753000
Quarters > 0 > cash Flow > net Change In Cash
17592000
Quarters > 0 > ratios > PE
-0.3151463980623985
Quarters > 0 > ratios > PB
4.066610948517189
Quarters > 0 > ratios > ROE
-31.257994945031857
Quarters > 0 > ratios > ROA
-13.137772329174155
Quarters > 0 > ratios > FCF
-35286000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-28.804897959183673
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1115000
Quarters > 1 > income Statement > cost Of Revenue
1864000
Quarters > 1 > income Statement > gross Profit
-749000
Quarters > 1 > income Statement > operating Expenses
52628000
Quarters > 1 > income Statement > operating Income
-53377000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-52591000
Quarters > 1 > income Statement > net Income
-52591000
Quarters > 1 > income Statement > eps
-0.40709545762639127
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
129185917
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-51513000
Quarters > 1 > income Statement > operating Margin
-4787.174887892377
Quarters > 1 > income Statement > total Other Income Expense Net
786000
Quarters > 1 > balance Sheet > cash
53804000
Quarters > 1 > balance Sheet > short Term Investments
47946000
Quarters > 1 > balance Sheet > receivables
120000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
121287000
Quarters > 1 > balance Sheet > property Plant Equipment
144031000
Quarters > 1 > balance Sheet > total Assets
279009000
Quarters > 1 > balance Sheet > payables
6378000
Quarters > 1 > balance Sheet > short Term Debt
7258000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
218149000
Quarters > 1 > balance Sheet > equity
60860000
Quarters > 1 > cash Flow > net Income
-52591000
Quarters > 1 > cash Flow > depreciation
1453000
Quarters > 1 > cash Flow > change In Working Capital
548000
Quarters > 1 > cash Flow > cash From Operations
-41412000
Quarters > 1 > cash Flow > capital Expenditures
1572000
Quarters > 1 > cash Flow > cash From Investing
2771000
Quarters > 1 > cash Flow > cash From Financing
197000
Quarters > 1 > cash Flow > net Change In Cash
-38444000
Quarters > 1 > ratios > PE
-0.40709545762639127
Quarters > 1 > ratios > PB
8.70296187479461
Quarters > 1 > ratios > ROE
-86.41307919815972
Quarters > 1 > ratios > ROA
-18.849212749409517
Quarters > 1 > ratios > FCF
-42984000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-38.55067264573991
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1454000
Quarters > 2 > income Statement > cost Of Revenue
1700000
Quarters > 2 > income Statement > gross Profit
1454000
Quarters > 2 > income Statement > operating Expenses
53846000
Quarters > 2 > income Statement > operating Income
-52392000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-51890000
Quarters > 2 > income Statement > net Income
-51890000
Quarters > 2 > income Statement > eps
-0.3964564479717956
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
130884490
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-50692000
Quarters > 2 > income Statement > operating Margin
-3603.3012379642364
Quarters > 2 > income Statement > total Other Income Expense Net
502000
Quarters > 2 > balance Sheet > cash
91877000
Quarters > 2 > balance Sheet > short Term Investments
52379000
Quarters > 2 > balance Sheet > receivables
17000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
163765000
Quarters > 2 > balance Sheet > property Plant Equipment
150336000
Quarters > 2 > balance Sheet > total Assets
328163000
Quarters > 2 > balance Sheet > payables
10025000
Quarters > 2 > balance Sheet > short Term Debt
6858000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
221239000
Quarters > 2 > balance Sheet > equity
106924000
Quarters > 2 > cash Flow > net Income
-51890000
Quarters > 2 > cash Flow > depreciation
1536000
Quarters > 2 > cash Flow > change In Working Capital
-7653000
Quarters > 2 > cash Flow > cash From Operations
-48857000
Quarters > 2 > cash Flow > capital Expenditures
2422000
Quarters > 2 > cash Flow > cash From Investing
-47742000
Quarters > 2 > cash Flow > cash From Financing
6000000
Quarters > 2 > cash Flow > net Change In Cash
-90599000
Quarters > 2 > ratios > PE
-0.3964564479717956
Quarters > 2 > ratios > PB
5.018764814260596
Quarters > 2 > ratios > ROE
-48.529796865063034
Quarters > 2 > ratios > ROA
-15.812264027327883
Quarters > 2 > ratios > FCF
-51279000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-35.26753782668501
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2183000
Quarters > 3 > income Statement > cost Of Revenue
1717000
Quarters > 3 > income Statement > gross Profit
2183000
Quarters > 3 > income Statement > operating Expenses
46405000
Quarters > 3 > income Statement > operating Income
-44222000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-42276000
Quarters > 3 > income Statement > net Income
-42276000
Quarters > 3 > income Statement > eps
-0.35645753954196824
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
118600381
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-42505000
Quarters > 3 > income Statement > operating Margin
-2025.744388456253
Quarters > 3 > income Statement > total Other Income Expense Net
1946000
Quarters > 3 > balance Sheet > cash
182476000
Quarters > 3 > balance Sheet > short Term Investments
7966000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
211886000
Quarters > 3 > balance Sheet > property Plant Equipment
71560000
Quarters > 3 > balance Sheet > total Assets
297508000
Quarters > 3 > balance Sheet > payables
11351000
Quarters > 3 > balance Sheet > short Term Debt
3614000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
144359000
Quarters > 3 > balance Sheet > equity
153149000
Quarters > 3 > cash Flow > net Income
-42276000
Quarters > 3 > cash Flow > depreciation
1717000
Quarters > 3 > cash Flow > change In Working Capital
48860000
Quarters > 3 > cash Flow > cash From Operations
16245000
Quarters > 3 > cash Flow > capital Expenditures
1791000
Quarters > 3 > cash Flow > cash From Investing
48253000
Quarters > 3 > cash Flow > cash From Financing
1000
Quarters > 3 > cash Flow > net Change In Cash
64499000
Quarters > 3 > ratios > PE
-0.35645753954196824
Quarters > 3 > ratios > PB
3.175088065217533
Quarters > 3 > ratios > ROE
-27.60448974528074
Quarters > 3 > ratios > ROA
-14.210038049396992
Quarters > 3 > ratios > FCF
14454000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
6.621163536417773
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2983000
Annuals > 0 > income Statement > cost Of Revenue
6128000
Annuals > 0 > income Statement > gross Profit
2983000
Annuals > 0 > income Statement > operating Expenses
205450000
Annuals > 0 > income Statement > operating Income
-202467000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-195882000
Annuals > 0 > income Statement > net Income
-195882000
Annuals > 0 > income Statement > eps
-1.6516135812413621
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
118600381
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-196339000
Annuals > 0 > income Statement > operating Margin
-6787.361716392893
Annuals > 0 > income Statement > total Other Income Expense Net
6585000
Annuals > 0 > balance Sheet > cash
182476000
Annuals > 0 > balance Sheet > short Term Investments
7966000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
211886000
Annuals > 0 > balance Sheet > property Plant Equipment
71560000
Annuals > 0 > balance Sheet > total Assets
297508000
Annuals > 0 > balance Sheet > payables
11351000
Annuals > 0 > balance Sheet > short Term Debt
3614000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
144359000
Annuals > 0 > balance Sheet > equity
153149000
Annuals > 0 > cash Flow > net Income
-195882000
Annuals > 0 > cash Flow > depreciation
6128000
Annuals > 0 > cash Flow > change In Working Capital
31076000
Annuals > 0 > cash Flow > cash From Operations
-122865000
Annuals > 0 > cash Flow > capital Expenditures
7294000
Annuals > 0 > cash Flow > cash From Investing
68457000
Annuals > 0 > cash Flow > cash From Financing
195876000
Annuals > 0 > cash Flow > net Change In Cash
141468000
Annuals > 0 > ratios > PE
-1.6516135812413621
Annuals > 0 > ratios > PB
2.555558686638502
Annuals > 0 > ratios > ROE
-127.90289195489359
Annuals > 0 > ratios > ROA
-65.84091856353442
Annuals > 0 > ratios > FCF
-130159000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-43.633590345289974
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
4653000
Annuals > 1 > income Statement > gross Profit
-4653000
Annuals > 1 > income Statement > operating Expenses
204792000
Annuals > 1 > income Statement > operating Income
-204792000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-198412000
Annuals > 1 > income Statement > net Income
-198133000
Annuals > 1 > income Statement > eps
-2.1780198505810646
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
90969327
Annuals > 1 > income Statement > income Tax Expense
-279000
Annuals > 1 > income Statement > EBITDA
-186639000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
6380000
Annuals > 1 > balance Sheet > cash
41574000
Annuals > 1 > balance Sheet > short Term Investments
80091000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
142976000
Annuals > 1 > balance Sheet > property Plant Equipment
36600000
Annuals > 1 > balance Sheet > total Assets
193851000
Annuals > 1 > balance Sheet > payables
19537000
Annuals > 1 > balance Sheet > short Term Debt
9276000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
60780000
Annuals > 1 > balance Sheet > equity
133071000
Annuals > 1 > cash Flow > net Income
-198133000
Annuals > 1 > cash Flow > depreciation
4653000
Annuals > 1 > cash Flow > change In Working Capital
2647000
Annuals > 1 > cash Flow > cash From Operations
-165412000
Annuals > 1 > cash Flow > capital Expenditures
8724000
Annuals > 1 > cash Flow > cash From Investing
18711000
Annuals > 1 > cash Flow > cash From Financing
655000
Annuals > 1 > cash Flow > net Change In Cash
-146046000
Annuals > 1 > ratios > PE
-2.1780198505810646
Annuals > 1 > ratios > PB
2.255929384313637
Annuals > 1 > ratios > ROE
-148.8926963801279
Annuals > 1 > ratios > ROA
-102.20891303114247
Annuals > 1 > ratios > FCF
-174136000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
5210000
Annuals > 2 > income Statement > cost Of Revenue
12014000
Annuals > 2 > income Statement > gross Profit
-12014000
Annuals > 2 > income Statement > operating Expenses
116544000
Annuals > 2 > income Statement > operating Income
-116544000
Annuals > 2 > income Statement > interest Expense
12129000
Annuals > 2 > income Statement > pretax Income
-122769000
Annuals > 2 > income Statement > net Income
-121821000
Annuals > 2 > income Statement > eps
-1.2531836874350581
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
97209213
Annuals > 2 > income Statement > income Tax Expense
-948000
Annuals > 2 > income Statement > EBITDA
-114320000
Annuals > 2 > income Statement > operating Margin
-2236.928982725528
Annuals > 2 > income Statement > total Other Income Expense Net
-6225000
Annuals > 2 > balance Sheet > cash
187620000
Annuals > 2 > balance Sheet > short Term Investments
106301000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
296618000
Annuals > 2 > balance Sheet > property Plant Equipment
48554000
Annuals > 2 > balance Sheet > total Assets
360314000
Annuals > 2 > balance Sheet > payables
4332000
Annuals > 2 > balance Sheet > short Term Debt
11694000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
44044000
Annuals > 2 > balance Sheet > equity
316270000
Annuals > 2 > cash Flow > net Income
-121821000
Annuals > 2 > cash Flow > depreciation
2224000
Annuals > 2 > cash Flow > change In Working Capital
-35401000
Annuals > 2 > cash Flow > cash From Operations
-131827000
Annuals > 2 > cash Flow > capital Expenditures
16095000
Annuals > 2 > cash Flow > cash From Investing
-47096000
Annuals > 2 > cash Flow > cash From Financing
181494000
Annuals > 2 > cash Flow > net Change In Cash
2571000
Annuals > 2 > ratios > PE
-1.2531836874350581
Annuals > 2 > ratios > PB
1.0142928602143737
Annuals > 2 > ratios > ROE
-38.518038384924274
Annuals > 2 > ratios > ROA
-33.80967711496084
Annuals > 2 > ratios > FCF
-147922000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-28.39193857965451
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
4861000
Annuals > 3 > income Statement > gross Profit
-4861000
Annuals > 3 > income Statement > operating Expenses
84474000
Annuals > 3 > income Statement > operating Income
-84474000
Annuals > 3 > income Statement > interest Expense
81770000
Annuals > 3 > income Statement > pretax Income
-165853000
Annuals > 3 > income Statement > net Income
-165367000
Annuals > 3 > income Statement > eps
-1.727428592481798
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
95730151
Annuals > 3 > income Statement > income Tax Expense
-486000
Annuals > 3 > income Statement > EBITDA
-83906000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-81379000
Annuals > 3 > balance Sheet > cash
185420000
Annuals > 3 > balance Sheet > short Term Investments
84200000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
270579000
Annuals > 3 > balance Sheet > property Plant Equipment
15678000
Annuals > 3 > balance Sheet > total Assets
301856000
Annuals > 3 > balance Sheet > payables
1435000
Annuals > 3 > balance Sheet > short Term Debt
7336000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
62296000
Annuals > 3 > balance Sheet > equity
239560000
Annuals > 3 > cash Flow > net Income
-165367000
Annuals > 3 > cash Flow > depreciation
568000
Annuals > 3 > cash Flow > change In Working Capital
31176000
Annuals > 3 > cash Flow > cash From Operations
-34082000
Annuals > 3 > cash Flow > capital Expenditures
4150000
Annuals > 3 > cash Flow > cash From Investing
-73626000
Annuals > 3 > cash Flow > cash From Financing
269278000
Annuals > 3 > cash Flow > net Change In Cash
161570000
Annuals > 3 > ratios > PE
-1.727428592481798
Annuals > 3 > ratios > PB
1.3187072061279013
Annuals > 3 > ratios > ROE
-69.0294706962765
Annuals > 3 > ratios > ROA
-54.78340665747906
Annuals > 3 > ratios > FCF
-38232000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.3151463980623985
Valuation > metrics > PB
4.066610948517189
Valuation > final Score
39.33389051482811
Valuation > verdict
35.6% Overvalued
Profitability > metrics > ROE
-31.257994945031857
Profitability > metrics > ROA
-21.858551636517635
Profitability > metrics > Net Margin
-41.29142857142857
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.3792462041391413
Risk > metrics > Interest Coverage
-28.69377990430622
Risk > final Score
-85
Risk > verdict
High
Liquidity > metrics > Current Ratio
13.557886102648231
Liquidity > metrics > Quick Ratio
13.557886102648231
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
29.81235185739404
Prev Valuations > 2
48.249119347824674
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-192
Prev Risks > 1
-157
Prev Risks > 2
-724
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:02:40.296Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.32
Earnings History > 0 > eps Estimate
-0.43
Earnings History > 0 > eps Difference
0.11
Earnings History > 0 > surprise Percent
25.5814
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.41
Earnings History > 1 > eps Estimate
-0.43
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
4.6512
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.4
Earnings History > 2 > eps Estimate
-0.44
Earnings History > 2 > eps Difference
0.04
Earnings History > 2 > surprise Percent
9.0909
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-28
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.31
Earnings History > 3 > eps Estimate
-0.49
Earnings History > 3 > eps Difference
0.18
Earnings History > 3 > surprise Percent
36.7347
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.44
Earnings History > 4 > eps Estimate
-0.49
Earnings History > 4 > eps Difference
0.05
Earnings History > 4 > surprise Percent
10.2041
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.46
Earnings History > 5 > eps Estimate
-0.49
Earnings History > 5 > eps Difference
0.03
Earnings History > 5 > surprise Percent
6.1224
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-10
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.44
Earnings History > 6 > eps Estimate
-0.47
Earnings History > 6 > eps Difference
0.03
Earnings History > 6 > surprise Percent
6.383
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-01
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.72
Earnings History > 7 > eps Estimate
-0.51
Earnings History > 7 > eps Difference
-0.21
Earnings History > 7 > surprise Percent
-41.1765
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-03
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.55
Earnings History > 8 > eps Estimate
-0.46
Earnings History > 8 > eps Difference
-0.09
Earnings History > 8 > surprise Percent
-19.5652
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-07
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.47
Earnings History > 9 > eps Estimate
-0.42
Earnings History > 9 > eps Difference
-0.05
Earnings History > 9 > surprise Percent
-11.9048
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.44
Earnings History > 10 > eps Estimate
-0.41
Earnings History > 10 > eps Difference
-0.03
Earnings History > 10 > surprise Percent
-7.3171
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-09
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.56
Earnings History > 11 > eps Estimate
-0.65
Earnings History > 11 > eps Difference
0.09
Earnings History > 11 > surprise Percent
13.8462
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.73
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.73
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-05-06
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.32
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.32
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-12-20
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.24
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.24
Earnings History > 14 > surprise Percent
-
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMarket Pulse: Why analysts upgrade PRME stock - Dividend Hike & Accurate Trade Setup Notifications moha.gov.vn
Read more →Prime Medicine's Market Cap Up US$161m Following Year Of Insider Stock Buying - simplywall.st
12/9/2025
Prime Medicine's Market Cap Up US$161m Following Year Of Insider Stock Buying simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$6.4643
Analyst Picks
Strong Buy
6
Buy
2
Hold
4
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 43.23% of the total shares of Prime Medicine, Inc. Common Stock
1.
Alphabet Inc(8.4491%)
since
2025/06/30
2.
T. Rowe Price Investment Management,Inc.(3.6375%)
since
2025/06/30
3.
ARK Genomic Revolution ETF(2.5815%)
since
2025/08/28
4.
BlackRock Inc(2.5163%)
since
2025/06/30
5.
FMR Inc(2.1004%)
since
2025/06/30
6.
Vanguard Group Inc(2.0348%)
since
2025/06/30
7.
Vanguard Total Stock Mkt Idx Inv(1.6723%)
since
2025/07/31
8.
T. Rowe Price Small-Cap Stock(1.3615%)
since
2025/07/31
9.
T. Rowe Price Small-Cap Value(1.3354%)
since
2025/07/31
10.
ARK Investment Management LLC(1.3029%)
since
2025/06/30
11.
ARK Genomic Revolution(1.272%)
since
2025/06/30
12.
T. Rowe Price U.S. SC Value Eq Tr-D(1.1916%)
since
2025/06/30
13.
Redmile Group, LLC(1.1636%)
since
2025/06/30
14.
MWG Management Ltd.(1.0053%)
since
2025/06/30
15.
Sumitomo Mitsui Trust Group Inc(0.8944%)
since
2025/06/30
16.
Amova Asset Management Americas, Inc(0.8914%)
since
2025/06/30
17.
Casdin Capital, LLC(0.8791%)
since
2025/06/30
18.
Geode Capital Management, LLC(0.8474%)
since
2025/06/30
19.
iShares Russell 2000 ETF(0.8021%)
since
2025/08/31
20.
State Street Corp(0.6952%)
since
2025/06/30
21.
T. Rowe Price Instl Small-Cap Stock(0.6877%)
since
2025/07/31
22.
Amova ARK Pstv Chg Innovt P JPY Acc(0.5776%)
since
2025/07/31
23.
Greenwich Wealth Management LLC(0.4747%)
since
2025/06/30
24.
Schonfeld Strategic Advisors LLC(0.4591%)
since
2025/06/30
25.
Farallon Capital Management, L.L.C.(0.4207%)
since
2025/06/30
26.
Vanguard Institutional Extnd Mkt Idx Tr(0.3914%)
since
2025/07/31
27.
Selectra J. Lamarck Biotech A(0.3814%)
since
2025/08/31
28.
Morgan Stanley - Brokerage Accounts(0.3296%)
since
2025/06/30
29.
Fidelity Small Cap Index(0.3283%)
since
2025/06/30
30.
iShares Biotechnology ETF(0.3159%)
since
2025/08/31
31.
Citadel Advisors Llc(0.2925%)
since
2025/06/30
32.
Charles Schwab Investment Management Inc(0.2909%)
since
2025/06/30
33.
Northern Trust Corp(0.2873%)
since
2025/06/30
34.
iShares Russell 2000 Value ETF(0.2839%)
since
2025/08/31
35.
Wanjia Glb Growth IY Hold Alloc (QDII) A(0.2805%)
since
2025/06/30
36.
Fidelity Extended Market Index(0.1973%)
since
2025/07/31
37.
Schwab US Small-Cap ETF™(0.1705%)
since
2025/08/30
38.
Vanguard Russell 2000 ETF(0.1565%)
since
2025/07/31
39.
Alger LIfe Sciences Innovation Composite(0.1521%)
since
2025/06/30
40.
CREF Stock R3(0.1165%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.32
EPS Estimate
-0.43
EPS Difference
0.11
Surprise Percent
25.5814%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.